Gene expression patterns that characterize advanced stage serous ovarian cancers

Journal of the Society for Gynecologic Investigation

Volumn 11, Issue 1, 2004, Pages 51-59

  Lancaster, Johnathan M ^b   Dressman, Holly K ^b   Whitaker, Regina S ^b   Havrilesky, Laura ^b   Gray, Jonathan ^b   Marks, Jeffrey R ^b   Nevins, Joseph R ^b   Berchuck, Andrew ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

Immune function; Microarray analysis; Ovarian cancer; Survival

Indexed keywords

MEMBRANE PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTADENOCARCINOMA; DNA MICROARRAY; EPITHELIUM; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; MORTALITY; NUCLEOTIDE SEQUENCE; OVARY; OVARY CARCINOMA; OVARY TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL MODEL; SURVIVAL RATE; VALIDATION PROCESS;

APOPTOSIS REGULATORY PROTEINS; CYSTADENOCARCINOMA, SEROUS; EPITHELIUM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNITY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; LINEAR MODELS; MEMBRANE GLYCOPROTEINS; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; OVARY; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL RATE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0346368077     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2003.07.004     Document Type: Article

References (23)

1. Berchuck A., Kohler M.F., Marks J.R., Wiseman R., Boyd J., Bast R.C. Jr. The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol. 170:1994;246-252.
2. Kohler M.F., Marks J.R., Wiseman R.W., et al. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J Natl Cancer Inst. 85:1993;1513-1519.
3. Havrilesky L., Alvarez A.A., Whitaker R.S., Marks J.R., Berchuck A. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations. Gynecol Oncol. 83:2001;491-500.
4. Reles A., Wen W.H., Schmider A., et al. Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. Clin Cancer Res. 7:2001;2984-2997.
5. Schmider A., Gee C., Friedmann W., et al. p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma. Gynecol Oncol. 77:2000;237-242.
6. Yu Y., Xu F., Peng H., et al. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci U S A. 96:1999;214-219.
7. Mok S.C., Chan W.Y., Wong K.K., Muto M.G., Berkowitz R.S. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. Oncogene. 12:1996;1895-1901.
8. Mok S.C., Chan W.Y., Wong K.K., et al. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene. 16:1998;2381-2387.
9. Abdollahi A., Godwin A.K., Miller P.D., et al. Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. Cancer Res. 57:1997;2029-2034.
10. Schultz D.C., Vanderveer L., Berman D.B., Hamilton T.C., Wong A.J., Godwin A.K. Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res. 56:1996;1997-2002.
11. Boyd J, Hamilton TC, Berchuck A. Oncogenes and tumor suppressor genes. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and practice of gynecologic oncology. New York: Lippincott, Williams & Wilkins, 2000:103-28.
12. Golub T.R., Slonim D.K., Tamayo P., et al. Molecular classification of cancer Class discovery and class prediction by gene expression monitoring . Science. 286:1999;531-537.
13. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 403:2000;503-511.
14. Wong K.K., Cheng R.S., Mok S.C. Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system. Biotechniques. 30:2001;670-675.
15. Welsh J.B., Zarrinkar P.P., Sapinoso L.M., et al. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci U S A. 98:2001;1176-1181.
16. Shridhar V., Lee J., Pandita A., et al. Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res. 61:2001;5895-5904.
17. Schummer M., Ng W.V., Bumgarner R.E., et al. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas. Gene. 238:1999;375-385.
18. Ono K., Tanaka T., Tsunoda T., et al. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res. 60:2000;5007-5011.
19. Sawiris G.P., Sherman-Baust C.A., Becker K.G., Cheadle C., Teichberg D., Morin P.J. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Res. 62:2002;2923-2928.
20. Jazaeri A.A., Yee C.J., Sotiriou C., Brantley K.R., Boyd J., Liu E.T. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst. 94:2002;990-1000.
21. Berchuck A., Rodriguez G.C., Olt G.J., et al. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β Am J Obstet Gynecol. 166:1992;676-684.
22. Gebauer G., Rieger M., Jager W., Lang N. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors. Anticancer Res. 19:1999;2509-2511.
23. Milliken D., Scotton C., Raju S., Balkwill F., Wilson J. Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites. Clin Cancer Res. 8:2002;1108-1114.